Search for: "Doe 35" Results 5301 - 5320 of 17,235
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Sep 2024, 6:56 am by John Holtz
When it comes to its reasoning, SBA stated: “SBA does not believe that the 35% HUBZone residency requirement should be watered down to as low as 20% over the course of a firm’s participation in the HUBZone program merely because a HUBZone small business concern received one or more HUBZone contracts. [read post]
18 Apr 2016, 9:58 am by Dennis Crouch
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
10 Apr 2010, 11:01 am by Oliver G. Randl
As the test mentioned in point 2.1.3 above is fulfilled, not specifying the material of the tubular element 32 in claim 1 does not offend against A 123(2). [read post]
31 Oct 2011, 5:40 pm by FDABlog HPM
RE 41,571 (“the ‘571 patent”), a method-of-use patent listed in the Orange Book covering BUTRANS (buprenorphine) Transdermal System is not eligible for a Patent Term Extension (“PTE”) because the product does not meet the first permitted commercial marketing prong of the PTE statute at 35 U.S.C. [read post]
17 Dec 2007, 9:57 am
 Since there was no valid approval, there was no valid notice of exemption and the 35-day statute of limitations did not begin to run. [read post]
19 Sep 2022, 7:33 pm by Dennis Crouch
  I might ask, if an AI is not an individual, does that mean it is a collective? [read post]
3 Nov 2010, 7:56 am by Susan Brenner
Count 35 of the indictment charges Alexander with aggravated identity theft in violation of 18 U.S. [read post]
17 Dec 2007, 9:57 am
 Since there was no valid approval, there was no valid notice of exemption and the 35-day statute of limitations did not begin to run. [read post]